Surrozen (SRZN) Competitors $11.16 -0.40 (-3.42%) As of 02/21/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SRZN vs. KYTX, TSVT, BDTX, IVA, CABA, NVCT, RENB, CRBU, CRBP, and MISTShould you be buying Surrozen stock or one of its competitors? The main competitors of Surrozen include Kyverna Therapeutics (KYTX), 2seventy bio (TSVT), Black Diamond Therapeutics (BDTX), Inventiva (IVA), Cabaletta Bio (CABA), Nuvectis Pharma (NVCT), Renovaro (RENB), Caribou Biosciences (CRBU), Corbus Pharmaceuticals (CRBP), and Milestone Pharmaceuticals (MIST). These companies are all part of the "pharmaceutical products" industry. Surrozen vs. Kyverna Therapeutics 2seventy bio Black Diamond Therapeutics Inventiva Cabaletta Bio Nuvectis Pharma Renovaro Caribou Biosciences Corbus Pharmaceuticals Milestone Pharmaceuticals Surrozen (NASDAQ:SRZN) and Kyverna Therapeutics (NASDAQ:KYTX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings, media sentiment and community ranking. Does the media favor SRZN or KYTX? In the previous week, Kyverna Therapeutics had 1 more articles in the media than Surrozen. MarketBeat recorded 1 mentions for Kyverna Therapeutics and 0 mentions for Surrozen. Surrozen's average media sentiment score of 0.00 equaled Kyverna Therapeutics'average media sentiment score. Company Overall Sentiment Surrozen Neutral Kyverna Therapeutics Neutral Which has higher valuation & earnings, SRZN or KYTX? Surrozen has higher revenue and earnings than Kyverna Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurrozen$12.50M2.91-$43.04MN/AN/AKyverna Therapeutics$7.03M17.07-$60.37MN/AN/A Is SRZN or KYTX more profitable? Kyverna Therapeutics' return on equity of -51.12% beat Surrozen's return on equity.Company Net Margins Return on Equity Return on Assets SurrozenN/A -120.51% -54.68% Kyverna Therapeutics N/A -51.12%-37.91% Do analysts rate SRZN or KYTX? Surrozen presently has a consensus price target of $38.50, suggesting a potential upside of 243.75%. Kyverna Therapeutics has a consensus price target of $25.71, suggesting a potential upside of 824.97%. Given Kyverna Therapeutics' higher possible upside, analysts clearly believe Kyverna Therapeutics is more favorable than Surrozen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surrozen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Kyverna Therapeutics 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of SRZN or KYTX? 66.6% of Surrozen shares are held by institutional investors. Comparatively, 18.1% of Kyverna Therapeutics shares are held by institutional investors. 43.5% of Surrozen shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in SRZN or KYTX? Kyverna Therapeutics received 5 more outperform votes than Surrozen when rated by MarketBeat users. Likewise, 66.67% of users gave Kyverna Therapeutics an outperform vote while only 25.00% of users gave Surrozen an outperform vote. CompanyUnderperformOutperformSurrozenOutperform Votes525.00% Underperform Votes1575.00% Kyverna TherapeuticsOutperform Votes1066.67% Underperform Votes533.33% SummaryKyverna Therapeutics beats Surrozen on 9 of the 13 factors compared between the two stocks. Get Surrozen News Delivered to You Automatically Sign up to receive the latest news and ratings for SRZN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRZN vs. The Competition Export to ExcelMetricSurrozenBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$37.53M$3.11B$5.84B$9.15BDividend YieldN/A1.55%4.75%3.85%P/E RatioN/A27.4925.4719.00Price / Sales2.91329.47447.5876.30Price / CashN/A168.8738.0134.83Price / Book0.613.687.644.62Net Income-$43.04M-$71.72M$3.18B$245.85M7 Day Performance-4.36%-2.50%-1.99%-2.68%1 Month Performance-4.27%-0.32%-0.42%-2.19%1 Year Performance-12.36%-12.32%16.51%12.84% Surrozen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRZNSurrozen3.0094 of 5 stars$11.20-3.0%$38.50+243.8%-18.2%$37.53M$12.50M0.0080KYTXKyverna Therapeutics1.1479 of 5 stars$3.01+0.3%$25.71+754.3%-89.9%$129.94M$7.03M0.0096TSVT2seventy bio2.1813 of 5 stars$2.45+6.5%$7.20+193.9%-53.2%$126.40M$100.39M-1.32440Analyst ForecastNews CoverageBDTXBlack Diamond Therapeutics3.3805 of 5 stars$2.23-9.3%$15.50+595.1%-53.7%$126.17MN/A-1.6890Short Interest ↓IVAInventiva1.999 of 5 stars$2.37-2.4%$13.25+458.8%-13.1%$124.43M$18.91M0.00100Analyst ForecastNews CoverageGap UpCABACabaletta Bio2.2422 of 5 stars$2.53-4.5%$22.71+797.8%-90.7%$123.67MN/A-1.1850Analyst ForecastNVCTNuvectis Pharma2.4047 of 5 stars$6.33-5.7%$21.00+231.8%+7.2%$122.30MN/A-5.468RENBRenovaro0.763 of 5 stars$0.75+7.5%N/A-61.1%$119.59MN/A-0.7820Earnings ReportNews CoverageGap UpCRBUCaribou Biosciences3.1342 of 5 stars$1.32-2.2%$10.33+682.8%-80.8%$119.53M$34.48M-0.80100CRBPCorbus Pharmaceuticals4.043 of 5 stars$9.78-3.6%$61.38+527.6%-69.9%$119.11MN/A-2.0940Analyst ForecastGap DownMISTMilestone Pharmaceuticals2.8119 of 5 stars$2.23+3.7%$13.00+483.0%+29.1%$118.93M$1M-2.7530 Related Companies and Tools Related Companies KYTX Competitors TSVT Competitors BDTX Competitors IVA Competitors CABA Competitors NVCT Competitors RENB Competitors CRBU Competitors CRBP Competitors MIST Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SRZN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surrozen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surrozen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRZN Stock Alerts